Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VerastemVSTM +0.59%14 OCF Margin % is -109.56% as of Jun. 2026. GuruFocus rates VSTM with a GF Score™ of 14/100. The stock has 6 warning signs investors should review. Among 953 Biotechnology companies, Verastem ranks worse than 61.59% on this metric.
The historical data trend for Verastem's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Verastem's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verastem OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Verastem's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Verastem's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verastem (VSTM) has a OCF Margin % of -109.56% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Verastem and its competitors. According to the industry distribution chart, Verastem ranks #587 out of 953 companies in the Biotechnology industry, placing it in the top 61.6%.
Is Verastem's OCF Margin % too high?
Verastem's current OCF Margin % is -109.56%. Based on the distribution chart, Verastem ranks #587 out of 953 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Verastem has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Verastem's OCF Margin % compare to PRME and ALT?
According to the Biotechnology industry distribution chart, Verastem ranks #587 out of 953 companies for OCF Margin %. This places Verastem in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Verastem and its competitors. Verastem's current OCF Margin % is -109.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verastem stock overvalued right now?
Verastem (VSTM) has a current OCF Margin % of -109.56%. The current OCF Margin % is -109.56%. Verastem's overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Verastem (VSTM), the current OCF Margin % is -109.56% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
14GF Score
Get the complete analysis for VSTM
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VSTM has been successfully added to your 
